Skip to main content

Table 1 Factors associated with tuberculosis among PLHIV between 2006 and 2011

From: A comparision of the yield of three tuberculosis screening modalities among people living with HIV: a retrospective quasi-experiemental study

Variable

All cohort

TB

No TB

Univariate

Multivariate

N = 2,458 (100)

n = 275 (11.18)

n = 2,183 (88.81)

OR

95 % CI

P–value

aOR

95 % CI

P–value

Age (years)

Mean (sd)

34.8 (11.5)

38.0 (11.7)

34.4 (11.5)

1.02

1.01 – 1.04

<0.001

1.03

1.01 – 1.03

<0.001

Gender

Female

1,505 (61.2)

175 (63.6)

1,329 (60.9)

1

 

0.38

   

Male

953 (38.7)

100 (36.4)

854 (39.1)

1.13

0.87 – 1.46

 

-

-

-

Education#

None

501 (21.8)

40 (15)

461 (22.7)

1

 

<0.001

1

  

Primary

993 (43.2)

134 (50.4)

859 (42.3)

1.80

124 – 2.61

 

1.72

1.18 – 2.51

0.005

Secondary

654 (28.5)

62 (23.3)

592 (29.1)

1.20

0.79 – 1.83

 

1.22

0.80 – 1.86

0.350

Tertiary

149 (6.5)

30 (11.3)

119 (5.9)

2.90

1.73 – 4.86

 

2.38

1.41 – 4.04

0.001

Missing

161 (6.5)

9 (3.27 %)

152 (6.96 %)

      

ART Status

No

546 (22)

22 (8)

524 (24)

1

 

<0.001

1

  

Yes

1912 (78)

253 (92)

1659 (76)

3.64

2.32–5.71

 

3.38

2.16 – 5.32

<0.001

Baseline CD4+

Median (IQR)

505 (200–720)

552 (286–782)

496 (192–712)

1.00

1.00.–1.00

<0.01

1.00

1.00 – 1.00

0.034

BMI

Mean (sd)

24.9 (5)

26.1 (5.3)

24.2 (4.9)

1.05

1.03–1.08

<0.001

1.05

1.02 – 1.07

0.001

  1. Abbreviations: ART antiretroviral therapy, aOR odds ratio adjusted for all variables with p < 0.25, BMI basal mass index, CD4+ cluster of differentiation, CI confidence interval, OR crude odds ratio, IQR inter quartile range, sd standard deviation, TB Tuberculosis, *Significance level of p < 0.05, () refers to percentage unless stated